Inhibitor Therapeutics Market Cap

Inhibitor Therapeutics has a market cap or net worth of $18.24 million as of March 6, 2026. Its market cap has decreased by -18.42% in one year.

Market Cap

18.24M

Enterprise Value

15.34M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.10

Market Cap Chart

Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 18.24M, an increase of 29.62%. That is a compound annual growth rate of 0.92%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	17.43M	124.44%
Dec 31, 2025	7.77M	-25.02%
Dec 31, 2024	10.36M	-34.56%
Dec 28, 2023	15.83M	-57.47%
Dec 28, 2022	37.21M	-34.06%
Dec 30, 2021	56.43M	332.16%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zenith Capital	19.17M
Oncotelic Therapeutics	19.26M
EOM Pharmaceuticals Holdings	20.24M
Provectus Biopharmaceuticals	20.59M
Finch Therapeutics Group	21.28M
Anebulo Pharmaceuticals	16.30M
Zeo ScientifiX	14.30M
HOOKIPA Pharma	13.25M

Market Cap Rankings